The SSS-8 measures somatic symptom burden - how much a person has been bothered over the past seven days by eight common bodily complaints: stomach or bowel problems, back pain, pain in the arms, legs or joints, headaches, chest pain or shortness of breath, dizziness, feeling tired or having low energy, and trouble sleeping. It quantifies the burden of symptoms regardless of whether a medical explanation exists, which matches the DSM-5 shift away from "medically unexplained" as a defining criterion.
It is a severity measure, not a diagnostic instrument. A high score signals a heavy symptom load worth clinical attention; it does not itself establish somatic symptom disorder, which additionally requires the psychological B-criteria (excessive thoughts, anxiety, time and energy devoted to symptoms) - those are captured by instruments such as the SSD-12, not the SSS-8.
02 - Origin & purpose
Where it comes from.
Developed by Benjamin Gierk, Sebastian Kohlmann, Kurt Kroenke and colleagues and published in JAMA Internal Medicine in 2014 (DOI: 10.1001/jamainternmed.2013.12179). It is an abbreviated derivative of the PHQ-15, created because DSM-5 field work needed a shorter somatic symptom measure with a one-week recall window suitable for repeated administration. It was validated in a representative German general-population survey (n = 2,510).
Purpose: a quick, repeatable index of somatic symptom burden for screening and monitoring - for example tracking treatment response in somatic symptom and related disorders, or flagging heavy somatic load in patients presenting with depression or anxiety.
03 - Scoring & cutoffs
How scoring works.
Eight items, each rated 0-4 (not at all, a little bit, somewhat, quite a bit, very much) for the past seven days; total 0-32. Severity bands from the original validation, derived from general-population percentile ranks: 0-3 no to minimal, 4-7 low, 8-11 medium, 12-15 high, 16-32 very high somatic symptom burden. In the validation study, each additional point was associated with a 12% increase in healthcare visits (incidence rate ratio 1.12), so band shifts are clinically meaningful.
Score
Severity
Interpretation
0–3
No to minimal
No to minimal somatic symptom burden.
4–7
Low
Low somatic symptom burden.
8–11
Medium
Medium somatic symptom burden.
12–15
High
High somatic symptom burden.
16–32
Very high
Very high somatic symptom burden. Further assessment recommended.
04 - Validation evidence
How well it performs.
In the original 2014 general-population validation the SSS-8 showed good reliability and expected convergent correlations: with depression r = 0.57, anxiety r = 0.55, and inversely with general health status r = −0.24. Later work confirmed a four-domain structure (gastrointestinal, pain, fatigue, cardiopulmonary) and adequate temporal stability, with translations validated in Korean, Brazilian Portuguese and other languages.
0.81
Cronbach's alpha
Internal consistency, original validation
0.57
r with depression
Convergent validity
0.70-0.78
Test-retest
Across longitudinal general-population studies
1.12
IRR healthcare visits
Per additional point on the scale
05 - How it compares
How it compares to the alternatives.
Instrument
Items
Time
When to reach for it
SSS-8
8
~1 min
Somatic symptom burden over the past 7 days; quick and repeatable.
The SSS-8 earns its place where somatic burden needs a number that can be repeated often. Its seven-day recall window is short enough for frequent review, but that same window is what makes it a poor fit for episodic complaints.
Reach for it when
-Quantifying somatic burden in psychiatric outpatients
-Repeated monitoring - the 7-day recall suits fortnightly or monthly review
-A quicker alternative to the PHQ-15 in time-pressured settings
-Flagging somatic load that may complicate depression or anxiety treatment
Reach for something else when
-Diagnosing somatic symptom disorder on its own - it captures no B-criteria
-Replacing medical assessment of new or evolving physical symptoms
-Children and adolescents - validation is in adults
-Attributing symptoms to psychological causes - the score is explanation-neutral
07 - Confidence & precision
Reading the score with care.
A formal SEM and minimal clinically important difference have not been firmly established for the SSS-8. With test-retest reliability around 0.70-0.78, treat movements within a single severity band cautiously; a change that crosses a full band (4 points or more) is a more dependable signal than a 1-2 point shift.
08 - Limitations
What it cannot tell you.
Severity bands come from general-population percentile ranks, not clinical outcome anchors; scores overlap substantially with depression and anxiety, so interpret alongside PHQ-9/GAD-7; the 7-day window misses fluctuating or episodic symptoms; norms are from a German sample; it omits symptom domains (e.g. menstrual, sexual) covered by the PHQ-15; a low score does not exclude serious somatic disease.
09 - Licensing, explained
How licensing works.
Free to use in clinical and research practice. Please reproduce it in full and keep the original publisher attribution.
See how Aisel removes friction where it costs most. A 20-minute walkthrough tailored to your clinic.
We value your privacy
We use cookies to analyse site usage and improve your experience. Analytics and embedded media (e.g. YouTube) only load if you accept. Read our cookie policy.